Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytokine-induced Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00394381
What this trial is testing

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome, High Grade
Singapore General Hospital 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02487693
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
The First People's Hospital of Changzhou 50
Not applicableStudy completedNCT01232062
What this trial is testing

Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Peking University Cancer Hospital & Institute 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02487550
What this trial is testing

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Who this might be right for
Renal Neoplasma
The First People's Hospital of Changzhou 1,200
Early research (Phase 1)Ended earlyNCT05256277
What this trial is testing

NK Cell Therapy for AML

Who this might be right for
AML
Zhejiang University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02491697
What this trial is testing

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer

Who this might be right for
Breast Cancer
The First People's Hospital of Changzhou 400
Testing effectiveness (Phase 2)UnknownNCT01839539
What this trial is testing

Study of DC-CIK to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Guangxi Medical University 60
Testing effectiveness (Phase 2)UnknownNCT01799083
What this trial is testing

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas

Who this might be right for
Solid TumorsB Cell Lymphoma
Han weidong 100
Not applicableStudy completedNCT07692607
What this trial is testing

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
LucasBio 25
Large-scale testing (Phase 3)UnknownNCT02280278
What this trial is testing

Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy

Who this might be right for
Stage III Colon Cancer
Sun Yat-sen University 550
Testing effectiveness (Phase 2)UnknownNCT03047525
What this trial is testing

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Who this might be right for
Colorectal CancerRenal Cell CarcinomaNasopharyngeal Carcinoma+1 more
Xiaoyi Huang 200
Large-scale testing (Phase 3)Study completedNCT02419677
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer
The First People's Hospital of Changzhou 60
Not applicableStudy completedNCT01395056
What this trial is testing

Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Peking University Cancer Hospital & Institute 23
Testing effectiveness (Phase 2)UnknownNCT01929499
What this trial is testing

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer

Who this might be right for
Colonic Neoplasms
Yanjuan Zhu 210
Large-scale testing (Phase 3)UnknownNCT01481259
What this trial is testing

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 120
Not applicableUnknownNCT01828008
What this trial is testing

Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas

Who this might be right for
Lymphomas
Han weidong 20
Testing effectiveness (Phase 2)Ended earlyNCT03393858
What this trial is testing

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Who this might be right for
CancerMesothelioma, Malignant
Capital Medical University 10
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Testing effectiveness (Phase 2)UnknownNCT02487017
What this trial is testing

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaNeoplasmsDigestive System Neoplasms
Shenzhen Hornetcorn Bio-technology Company, LTD 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02497898
What this trial is testing

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
The First People's Hospital of Changzhou 1,000
Next Page